Tag: ASX:BOT

Botanix Pharmaceuticals Releases Quarterly Cash Flow Report

Botanix announced a widened product portfolio and progress in its clinical trials as a part of its quarterly activities report.

Botanix Pharmaceuticals Shares Phase 2 Results for BTX 1503

Botanix Pharmaceuticals, a medical dermatology company, released new key findings for a Phase 2 study of its BTX 1503 product.